Literature DB >> 644395

Arachnoiditis ossificans. Report of a case.

L Nainkin.   

Abstract

Arachnoiditis ossificans is uncommon and has been reported to occur in areas surrounding the brain stem, the spinal cord, and the cauda equina. Predisposing etiologic factors include vascular anomalies, spinal anesthetics, and meningitis. This report adds a case of arachnoiditis ossificans about the cauda equina occurring after septic complications following laminectomy. Surgical excision of the ossific tissue resulted in clinical improvement.

Entities:  

Mesh:

Year:  1978        PMID: 644395     DOI: 10.1097/00007632-197803000-00015

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  5 in total

1.  Spinal arachnoiditis ossificans. Observations on its investigation and treatment.

Authors:  T Shiraishi; H V Crock; A Reynolds
Journal:  Eur Spine J       Date:  1995       Impact factor: 3.134

2.  Arachnoid ossificans of thoracolumbosacral spine in the advanced ankylosing spondylitis: a case report.

Authors:  Kyung Bin Joo; Seunghun Lee; Chang-Nam Kang; Tae-Hwan Kim
Journal:  Rheumatol Int       Date:  2011-12-25       Impact factor: 2.631

3.  Arachnoid ossificans containing metaplastic hematopoietic marrow resulting in diffuse thoracic intrathecal cysts and severe myelopathy.

Authors:  Joshua Abrams; Gordon Li; Stefan A Mindea; Claudia M Haynes; Ivan Cheng
Journal:  Eur Spine J       Date:  2011-09-04       Impact factor: 3.134

Review 4.  The leptomeninges as a critical organ for normal CNS development and function: First patient and public involved systematic review of arachnoiditis (chronic meningitis).

Authors:  Carol S Palackdkharry; Stephanie Wottrich; Erin Dienes; Mohamad Bydon; Michael P Steinmetz; Vincent C Traynelis
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752

5.  Symptomatic arachnoiditis ossificans. Report of two cases.

Authors:  I R Whittle; N W Dorsch; J N Segelov
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.